Background: Total elbow arthroplasty is a low-volume procedure. The indications and implants have evolved in recent times. This study evaluates the complication rates associated with each of the most frequently used contemporary implants and the most common indications. Methods: A systematic literature search was undertaken of all studies reporting complications following total elbow arthroplasty with minimum 12-month follow-up. Each included study was assessed and scored using the Methodological Index for Non-Randomised Studies criteria. The complication rates were extracted and cumulative rates calculated. Results: A total of 117 studies were identified and screened with 25 studies included, totaling 1185 procedures. The overall complication rate was significantly higher than that seen following arthroplasty in other joints including a deep infection rate of 3%. Aseptic loosening is a concern with a cumulative rate of 12%, although this was much higher in the osteoarthritis and Latitude groups. Implant failure, predominantly due to bushing wear, was highest in the Coonrad-Morrey group. Conclusions: This is the largest systematic review in the literature for the complications of total elbow arthroplasty. It has demonstrated the overall complication rates for the most commonly used total elbow arthroplasty implants and indications. Surgeons should be aware of the differing complications related to their implant of choice and the indication for its use.
Background
Total elbow arthroplasty (TEA) is a low-volume procedure with only 430 individual cases recorded in England, Wales and Northern Ireland in 2017. 1 This is compared to nearly 7000 shoulder replacements, over 90,000 hip replacements and over 100,000 knee replacements performed during the same period. 1 Historically, TEA has been performed primarily for inflammatory arthropathy and post-traumatic arthritis. The outcomes for both of these indications have been good, especially so for rheumatoid arthritis and it is because of this that TEA has been used for an increasing variety of indications including osteoarthritis, haemophilic arthropathy, tumour resection and fracture non-union. 2, 3 TEA has also been utilised to provide a more predictable outcome following acute intra-articular fractures around the elbow, with promising results reported. 4, 5 Despite the expansion in its perceived indications for use, it is estimated that each surgeon in the UK performs between two and three total elbow replacements a year. 1 This is notable, given the current drive to limit the number of surgeons performing low-volume procedures in England, in an attempt to reduce unwarranted variation and decrease complication rates. 1, 6 There are several national joint registries (NJR) that include TEA. 1, 7, 8 At the time of this study, the largest series held on a single registry was 2229 cases, on the UK NJR. 1 This series involves eight different implants, although more than 95% of procedures were performed using the Latitude (Wright Medical, Memphis, Tennessee, USA) 13%, Discovery (DJO Global, Vista, California, USA) 29% or Coonrad-Morrey prosthesis (Zimmer, Warsaw, Indianapolis, USA) 57%. 1 The fourth most frequently implanted prosthesis, the GSB III (Zimmer, Warsaw, Indianapolis, USA), was used in just 2% of cases. 1 National joint registry data are important to track the performance of an implant and provide early warning of an unexpectedly high failure rate. 1 However, NJRs currently only report survival or revision rates for implants and do not specifically report complications. This combined with the high probability that most surgeons are performing less than five cases per year, highlights the need for a study specifically investigating the complication rates reported after TEA. The complication rates related to specific indications have also not previously been published.
The aims of this study, therefore, were to investigate the complication rates of TEA and highlight any variations in complications seen between different contemporary implants and the indications for their use.
Methods

Study rationale
A preliminary literature search revealed a large number of small studies reporting complications from TEA performed using implants with low-volume usage or for uncommon indications. To ensure that the results of this study were as relevant and transferable as possible, the decision was made to focus on investigating complications from the three most frequently used implants in the UK and for the most common indications. These are:
Prosthesis:
(i) Coonrad-Morrey (Zimmer, Warsaw, Indianapolis, USA) (ii) Latitude (Wright Medical, Memphis, Tennessee, USA) (iii) Discovery (DJO Global, Vista, California, USA) Indication:
Inflammatory arthropathy Osteoarthritis Trauma
A systematic review of the literature was then undertaken in accordance with Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. 9
Search strategy
A systematic review was performed in MEDLINE, EMBASE and the Cumulative Index to Nursing and Allied Health Literature databases through OvidSP. The search strategy was designed using the Medical Subject Heading terms 'Elbow', 'Arthroplasty', 'Replacement', 'Osteoarthritis', 'Fractures' and 'Arthritis, Rheumatoid' combined with British Medical Journal systematic evidence filters for interventional trials. The final search was performed on 19 February 2018. The references for each study were checked to ensure other relevant studies not initially highlighted were included. Duplicates were checked and if two or more studies appeared to involve the same patient population only the most recent study was included.
Eligibility criteria
Studies were included if they were on human patients, were written in English, printed or published online and reported complications from TEA. For the purposes of this review, the authors used Sokol's definition of a complication as 'any undesirable, unintended and direct result of an operation affecting the patient, which would not have occurred had the operation gone as well as could reasonably be hoped'. 10 Studies were excluded if they had a follow-up period of less than 12 months, contained less than five patients, were systematic reviews or meta-analyses or included patients undergoing revision, tumour or instability surgery. Studies were also excluded if they presented data on a mixture of implants or pathologies or involved patients that had a previous known peri-prosthetic infection, proximal ulnar synostosis or needed additional reconstructive surgery.
Study selection
All titles and abstracts were reviewed and assessed by two authors using a purposely designed systematic review programme (Rayyan QCRI, Qatar Computing Research Institute, Doha, Qatar). 11 Disagreements were reviewed together and settled by consensus with a third independent author. After initial screening and exclusion, the remaining full texts were retrieved and the eligibility criteria applied.
Data evaluation
The methodological quality of each study was assessed using the Methodological Index for Non-Randomised E Parker et al. 12 This is a validated scoring system that allows a maximum score of 16 for noncomparative studies and 24 for comparative studies. 12 
Results
The initial search revealed 117 studies and 25 met the eligibility criteria after screening ( Figure 1 ). The complications for each indication and implant are presented in Tables 1 and 2 . The assessment of study methodological quality is presented in Table 3 .
Discussion
This is the first study to specifically review the complications associated with the most frequently used TEA implants and the most common pathologies for which they are indicated. Aseptic loosening remains the greatest problem for all TEA groups, with around 12% of all patients experiencing loosening of one or both components. This was found to be much higher in the osteoarthritis (OA) group and amongst all pathology groups the ulnar component is affected more frequently than the humeral component. With a mean follow-up of less than five years for all pathologies within this review, this is a significant concern.
A high rate of deep infection was also highlighted at around 3% of all TEA when analysed per indication. This is substantially higher than in comparative joints such as the hip where peri-prosthetic infection rates of between 0.2% and 1.6% are quoted, depending on the methodology and study follow-up time. 38 Records aŌer duplicates removed 
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Ulnar neuropathy was the most common nerve injury across all groups, although this is usually a transient concern. 39 There were similar rates for all three implants ranging from 3.7% to 4.8%; however, when analysed by indication, the OA group was particularly affected by this complication, albeit with very small patient numbers included.
The rates of component wear and mechanical failure seen in this study are also higher than that seen following other joint replacements, due in large part to the presence of bushing components that form the bearing surface in the Coonrad-Morrey implant. The presence of linking pin dissociation was demonstrated on X-rays within several of the papers reporting on the Coonrad-Morrey implant. 21, 28, 32 This mechanism was described as bushing wear and not reported as a separate mode of failure. This mechanism was reported separately for the Discovery elbow in one paper at a rate of 6.5%. The authors report that a change in implant design was introduced to counter this complication in 2008. 13 There appears to be a similar rate of peri-prosthetic fracture overall when compared to the literature on other joint replacements, which range from 0.1% to 18% following total hip arthroplasty, 0.3% to 5.5% following total knee arthroplasty and 0.5% to 3% post total shoulder arthroplasty. 40 The rate was significantly higher in the Discovery group, however, potentially reflecting a different stress-riser profile inherent in the design of this implant.
When complications are stratified by implant, the Latitude had the highest complication rate overall, predominantly reflected in the much higher rate of aseptic loosening compared to the other implants. This implant also had a higher rate of deep infection than the other two implants combined. It is important to note that this group contained both constrained and non-constrained prostheses and radial components were not used in all of the total elbow replacements. The authors commented on a high rate of aseptic loosening within the radial component which may account for the high rate of aseptic loosening seen in the overall group.
The Coonrad-Morrey had the highest rate of implant failure (predominantly due to bushing wear). It can also be seen that intra-operative fracture, triceps weakness and rupture are also reported more in this group. The follow-up for these implants within the studies was longer which could potentially increase the rate of reported complications.
Implant failure and complication rates may also be affected by improvements in surgical technique (e.g. cementing technique) and also differing approaches (e.g. 'triceps on' versus 'triceps off') used over this period. This, however, could not be evaluated in the constraints of this study.
Predictably, the longest follow-up periods were seen in the inflammatory arthropathy group and for the Coonrad-Morrey implant. This should increase the likelihood of a complication being reported in these groups, especially aseptic loosening, but this was not the case. It is important to note that aseptic loosening is frequently reported both in general and specific to the location (i.e. ulna or humerus). In this review, all causes of loosening have been grouped together and include those reported without a specific location, although if a specific location of loosening was reported, this was also presented. Notably this was only reported in the studies using the Coonrad-Morrey implant. 
Despite these discrepancies, patterns do emerge from the data. This review does suggest that the OA group has a much higher complication rate when compared to the trauma or inflammatory groups, which were similar. The overall complication rate in the OA patients is above 100%, as the rates are not summative, demonstrating that some patients had more than one complication.
There is also a discrepancy in the total number of procedures included in Tables 1 and 2 . This relates to some studies not reporting the complications by specific indication and hence these could not be included in Table 1 .
The UK Joint Registry was used to determine the most common implants and indications for this study and the authors would comment that geographical variations in populations and surgical practice may lead to some variation in extrapolating this data. Despite this, however, the core indications and prosthesis type are commonly used internationally and data from across all published literature internationally was used for this systematic review.
The MINORS scoring criteria highlighted that the overall quality of the papers included in this review was low with an overall mean follow-up length of only 3.8 years. Further long-term follow-up studies and studies with higher quality methodologies would greatly assist in improving the accuracy of the estimated complication rates. It is particularly relevant that the estimation of complications in the OA group is hampered by the significant paucity of available data for follow-up beyond 12 months.
This study defined a complication as 'any untoward event' in an effort to anchor the study to a patientcentred overview; however, it is recognised that reporting of all complications under this definition is not universally applied in implant surveillance studies. In view of these elements, the authors feel that the cumulative complication rates may be under rather than over representative. It should also be noted that this study was unable to quantify patient-focused outcomes and would echo calls for future complication reporting and survival estimates to be complimented with patient reported outcome measures. 41 
Conclusion
This study reflects the current use of TEA and highlights the lack of literature reporting mid-and long-term outcomes for these implants. It is also evident that the overall complication rate for TEA is high and much higher than arthroplasty in other joints. This is likely to be related to the implant design, patient selection, surgical technique and the biomechanical demands that patients put on their implants following surgery. However, the representative contribution of these elements is unknown and should remain a focus of future research. It is, however, vital that surgeons are aware of the risk profile of this surgery and counsel their patients appropriately.
Surgeons should also be aware that rates of aseptic loosening are over 10% in less than five years, regardless of the implant or indication. Furthermore, it is important to recognise that complication rates in patients with OA may be higher than those for trauma and inflammatory arthropathy and that each implant has a specific set of complications that feature more frequently with its use.
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